Jordan E Lake

• University of Texas Hlth Sci Ctr Houston

  Professor of medicine

Sources: reporter.nih.gov

• National Heart, Lung, and Blood Institute

  R34, Preparing for Semaglutide Microdosing to Maintain Cardiovascular Health in People with HIV: The (pre-)SMASH CVD Trial, R34HL182386, 2026–2029, 8 Jul 2026

• National Heart, Lung, and Blood Institute

  R01, Evaluation of Glucagon-Like Peptide-1 Receptor Agonist on Pathophysiology of Inflammation and Atherosclerosis in Persons Living With HIV: A Multicenter Randomized Placebo-Controlled Tri, R01HL184987, 2026–2031, 7 Jul 2026

• National Institute of Diabetes and Digestive and Kidney Diseases

  R01, Incretin Microdosing for Cardiometabolic Health in People With HIV: The REINFORCE Trial, R01DK142171, 2025–2028, 10 Sept 2025

• National Institute of Allergy and Infectious Diseases

  R01, Estrogen's Impact on IgG Glycomic Modulation of Immunity and Inflammation During HIV, R01AI189353, 2025–2029, 18 Aug 2025

Sources: reporter.nih.gov